Marianne Baastrup Søndergaard

10PUBLICATIONS
15CO-AUTHORS
Liquid biopsiesEconomic models and forecastingAllergyRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 18, 2026
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study.

Galathea Berner, Marianne Baastrup Soendergaard, Susanne Hansen

|Mar 05, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis.

Kjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh

|Nov 27, 2025
Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma.

Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard

|Jul 15, 2025
Biologic Prescription Patterns and Biomarker Determinants of First-Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis.

Marianne Baastrup Soendergaard, Kjell Erik Julius Håkansson, Susanne Hansen

|Feb 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma.

Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh

|Jan 09, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma.

Marianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen

Pageof 2